Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients

Sponsor
Stanford University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04480411
Collaborator
(none)
0
1
1
11
0

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the use of technology including remote vital sign monitoring in improving quality of patient care, decreasing hospital admissions and re-admissions, decreasing hospital length of stay and decreasing use of personal protective equipment.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Doctorgram Patient Kit
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Use of Technology and Telemedicine to Improve Quality of Care in COVID 19 Patients
Anticipated Study Start Date :
Jan 1, 2022
Anticipated Primary Completion Date :
Dec 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: COVID-19 Patients

Patients that are admitted to the hospital with COVID 19.

Behavioral: Doctorgram Patient Kit
Participants will use the Doctorgram Patient Kit for remote monitoring and remote use stethoscope.

Outcome Measures

Primary Outcome Measures

  1. Patient provider experience survey score [Once after completion of device use (up to 15 minutes to complete the survey)]

    Five questions related to satisfaction with experience using home pulse oximetry, each on a scale of 1 (poor) to 5 (excellent) summed and averaged for an overall range of 1 to 5 (higher scores = better experience).

  2. Provider experience survey score [Once after completion of device use (up to 15 minutes to complete the survey)]

    Four questions related to satisfaction with experience using home pulse oximetry, each on a scale of 1 (poor) to 5 (excellent) summed and averaged for an overall range of 1 to 4 (higher scores = better experience).

  3. Use of personal protective improvement [6 months]

    Level of personal protective improvement in an in-patient setting.

  4. Number of in-patient encounters with COVID patients as a measure of provider exposure to high risk illness [6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Hospitalized patient with COVID 19 or outpatient under investigation for or diagnosed with COVID 19

  • Clinically stable (on 4L O2 or less, non ICU)

  • Demonstrates ability to be trained in use of digital stethoscope technology

Exclusion Criteria:
  • Pregnancy

  • Delirium

Contacts and Locations

Locations

Site City State Country Postal Code
1 Stanford University Stanford California United States 94305

Sponsors and Collaborators

  • Stanford University

Investigators

  • Principal Investigator: Ritu Parikh, MD, Stanford University
  • Principal Investigator: Julieta M Gabiola, MD, Stanford University
  • Principal Investigator: Nicholas Scoulios, MD, Stanford University
  • Principal Investigator: Lisa Shieh, MD, Stanford University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Stanford University
ClinicalTrials.gov Identifier:
NCT04480411
Other Study ID Numbers:
  • 56472
First Posted:
Jul 21, 2020
Last Update Posted:
Jan 31, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Stanford University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 31, 2022